Morgan Stanley analyst and Tesla Inc (NASDAQ:TSLA) bull Adam Jonas forecasts Tesla’s revenue from its energy segment to rise this year as its core EV business witnesses a revenue fall. What Happened: Jonas values Tesla Energy at $36 per share of his $310 price…
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. TD Cowen analyst Max Rakhlenko upgraded the rating for…
Amazon.com Inc. (NASDAQ:AMZN) reportedly plans a major overhaul of its Alexa service, integrating conversational generative AI. The project, known internally as “Banyan,” will introduce a two-tier system with a premium version potentially costing around $5 monthly, marking the first major…
Peter Schiff, a well-known economist and Bitcoin (CRYPTO: BTC) critic, recently expressed his views on the King Crypto in the context of AI giant Nvidia’s blockbuster run at the stock markets. What Happened: On Tuesday, Schiff took to X, formerly…
In a recent announcement that has stirred the auto industry, Elon Musk, CEO of Tesla Inc. (NASDAQ:TSLA), has hinted at the possibility of a Tesla Model Y priced under $20,000. However, experts have given mixed reactions to the revelation. What…
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the “Fear” zone on Thursday. U.S. stocks settled mixed on Thursday, with the S&P 500 recording a fourth consecutive closing…
Crypto trader Eugene Ng Ah Sio shared his perspective on why Ethereum (CRYPTO: ETH) is currently undervalued and suggests when the market provides opportunities, one should not overthink. What Happened: Eugene Ng Ah Sio highlighted that the current cycle has…
Eli Lilly and Co (NYSE:LLY) shared detailed results from the SYNERGY-NASH phase 2 study on Saturday. This trial involved 190 patients, both with and without type 2 diabetes, evaluating tirzepatide in adults with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and stage…
A California federal judge has reportedly allowed litigation to proceed against Abbott Laboratories (NYSE:ABT) regarding its Glucerna shakes and nutritional powders. The lawsuit claims these products, marketed as suitable for people with diabetes, contain harmful ingredients. U.S. District Judge P.…
Kirkland’s Inc (NASDAQ:KIRK) reported a first-quarter FY24 sales decline of 5.3% year-on-year to $91.75 million, missing the analyst consensus estimate of $93.07 million. Comparable sales decreased 3.5% versus last year, including a 19.1% decline in e-commerce sales and a 2.8%…